Stay updated on GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial
Sign up to get notified when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.

Latest updates to the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new site revision v3.5.0 was added to the record history, and revision v3.4.3 was removed.SummaryDifference0.1%

- Check26 days agoChange DetectedLatest revision updated to v3.4.3, replacing the previous v3.4.2 in the page history.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision v3.4.2 was added to the history; the prior funding notice and v3.4.1 entry were removed.SummaryDifference0.8%

- Check62 days agoChange DetectedAdded a site-wide notice regarding government funding delays and updated the revision from v3.4.0 to v3.4.1.SummaryDifference0.8%

- Check69 days agoChange DetectedAdded a 'Show glossary' option, color-coded highlights for additions (green) and deletions (red) in the study history, and a revision note showing v3.4.0 replacing v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check76 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no changes to study data or page content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.